{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,22]],"date-time":"2025-06-22T04:04:28Z","timestamp":1750565068946,"version":"3.41.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Neuroendocrine tumors (NETs) are rare neoplasms arising from enterochromaffin cells, which are predominantly noted in the gastrointestinal tract and lung; metastases of NETs to the testes in NET are further uncommon. Testicular NET usually has no symptoms and\/or presents with painless swelling of the scrotum. Detection of testicular lesion can be challenging and frequently missed on conventional radiological imaging. We present testicular NET missed on conventional radiological imaging, where <jats:sup>68<\/jats:sup>Ga-DOTATATE PET\/CT imaging detected the testicular lesion, and further evident on <jats:sup>177<\/jats:sup>Lu-DOTATATE\u2013based post\u2013peptide receptor radionuclide therapy theranostic imaging.<\/jats:p>","DOI":"10.1097\/rlu.0000000000004846","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T22:00:08Z","timestamp":1696456808000},"page":"1051-1052","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Testicular Metastasis From Neuroendocrine Tumors"],"prefix":"10.1097","volume":"48","author":[{"given":"Rahul V.","family":"Parghane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandip","family":"Basu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,9,21]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.annonc.2020.03.304","article-title":"Gastroenteropancreatic neuroendocrine neoplasms: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"31","year":"2020","journal-title":"Ann Oncol"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11912-021-01029-7","article-title":"Epidemiology, incidence, and prevalence of neuroendocrine neoplasms: are there global differences?","volume":"23","year":"2021","journal-title":"Curr Oncol Rep"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/BF02234798","article-title":"Testicular metastasis from ileal carcinoid: report of a case","volume":"44","year":"2001","journal-title":"Dis Colon Rectum"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"e240042","DOI":"10.1136\/bcr-2020-240042","article-title":"Metastatic neuroendocrine tumour presenting as a testicular mass","volume":"14","year":"2021","journal-title":"BMJ Case Rep"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.anndiagpath.2004.01.008","article-title":"Testicular metastasis of primary cecal carcinoid tumor","volume":"8","year":"2004","journal-title":"Ann Diagn Pathol"},{"key":"bib6-20250621","first-page":"3614387","article-title":"Primary carcinoid tumor of the testis: a case report and review of the literature","volume":"2018","year":"2018","journal-title":"Case Rep Urol"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000471879","article-title":"ENETS consensus guidelines for the standards of care in neuroendocrine tumors: radiological, nuclear medicine & hybrid imaging","volume":"105","year":"2017","journal-title":"Neuroendocrinology"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000447146","article-title":"Neuroendocrine testicular tumors: a systematic review and meta-analysis","volume":"10","year":"2017","journal-title":"Curr Urol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004846","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:08:18Z","timestamp":1750532898000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004846"}},"subtitle":["Imaging and Theranostics Through 68Ga-DOTATATE PET\/CT and 177Lu-DOTATATE\u2013Based Peptide Receptor Radionuclide Therapy"],"short-title":[],"issued":{"date-parts":[[2023,9,21]]},"references-count":8,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004846","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"type":"electronic","value":"1536-0229"},{"type":"print","value":"0363-9762"}],"subject":[],"published":{"date-parts":[[2023,9,21]]}}}